Vaxart, Inc. Gains 21.9%
Fri, Jun 11, 2021 at 05:30 PM
Vaxart, Inc. (VXRT:NASDAQ) jumped higher at $8.74, representing a gain of 21.9%. On Thu, Jun 10, 2021, VXRT:NASDAQ touched a New 2-Week Intraday High of $7.7. The stock got featured on our News Catalysts scanner on Tue, Jun 08, 2021 at 08:25 AM in the 'MISCELLANEOUS' category. From Thu, May 27, 2021, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Fri, Apr 30, 2021 at $11.11 with a volume of 112M+, and its share price has been moving sideways in recent weeks.
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- Novan, Inc. (NOVN:NASDAQ), 62.39%
- BAOS (BAOS:NASDAQ), 58.23%
- Urban One, Inc. (UONE:NASDAQ), 33.2%
- PROG (PROG:NASDAQ), 28.92%
- Iconix Brand Group, Inc. (ICON:NASDAQ), 27.76%
- EQOS (EQOS:NASDAQ), 25.81%
- Carver Bancorp, Inc. (CARV:NASDAQ), 24.22%
- Xinyuan Real Estate Co., Ltd. (XIN:NYSE), 23.55%
- Vaxart, Inc. (VXRT:NASDAQ), 21.9%
- The9 Limited (NCTY:NASDAQ), 20.69%